COL11A2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

DNA lentivector for transduction information

Lentiveral packaging plasmid DNA for non-viral plasmid transfection and direct use in plasmid expression. This DNA can alos be used for packaging into Lentiviral particles for high efficiency transduction and stably integrated expressions. GENTAUR suggests to use our ABM packaging mix LV003 of second generation virusses or the LV053, our 3rd Generation Packaging mixture. pLenti lentiviral plasmids DNAs are stored in 10milliMolar Tris/HCI with 1mM EDTA at a pH of 8 at -25 C. Vectors with selection markers like kanamycin, puromycin or cumate are available.
Lentiviral technical files
Lentivirus references
Properties

Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.

Gene target

COL11A2 Lentiviral Vector EF1a pLenti-GIII-EF1a
Gene symbol

PLA2G3, COL11A2
Short name

COL11A2 Lentiviral Vector ( ) (EF1a) (pLenti-GIII-EF1a)
Technique

Vectors
Species

Human, Humans
Alternative name

collagen, classification XI, a 2 Lentiviral integrating Desoxyribonucleic acid sequence (H. sapiens) (EF1a) (pLenti-GIII-EF1a)
Alternative to gene target

collagen, type XI, alpha 2, DFNA13 and DFNB53 and FBCG2 and HKE5 and PARP and STL3, COL11A2 and IDBG-82068 and ENSG00000204248 and 1302, protein binding, Extracellular, Col11a2 and IDBG-169769 and ENSMUSG00000024330 and 12815, COL11A2 and IDBG-628894 and ENSBTAG00000000601 and 515435

Name

Artificial Gene Fusion
Concept

Scope note: The in vitro fusion of GENES by RECOMBINANT DNA techniques to analyze protein behavior or GENE EXPRESSION REGULATION, or to merge protein functions for specific medical or industrial uses.
Tree numbers
- E05.393.220.250
Qualifiers

drug effects, methods, radiation effects